FDA Delays Approval of Actemra

Thanks.  You are correct, I misspoke, it is not a self-injected drug.  The reccommended dosage is 8mg/kg given by 60-minute IV drip infusion once every 4 weeks.

I took the adverse reaction information from the Roche website (www.rocheusa.com) and the FDA website  (www.fda.gov) (Roche's Actemra applications and addenda) as well as other articles that I have read.  As I said in the post, it does appear that several of the adverse events reported for Actemra are similar to those reported for TNF inhibitors and rituxan- most commonly serious infections and infusion reactions (hypersensitivity reactions and anaphylaxis).

Guys, let's stop fighting over petty details and tone down the technical talk.  Are we forgetting that this is a blog about RA, not a course in pharmacology?  I want to hear about personal stories that relate to RA, not info from Roche's website.  Thanks.

Jason